Immix Biopharma
IMMX
IMMX
16 hedge funds and large institutions have $1.39M invested in Immix Biopharma in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 0 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$43.4K | |
| 2 | +$41K | |
| 3 | +$20.7K | |
| 4 |
BlackRock
New York
|
+$8.01K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.92K |
Top Sellers
| 1 | -$539K | |
| 2 | -$195K | |
| 3 | -$29K | |
| 4 |
PA
Parallel Advisors
San Francisco,
California
|
-$7.77K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$323 |